He Xiao

753 total citations
41 papers, 572 citations indexed

About

He Xiao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, He Xiao has authored 41 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in He Xiao's work include Urinary Bladder and Prostate Research (5 papers), Sexual function and dysfunction studies (4 papers) and MicroRNA in disease regulation (4 papers). He Xiao is often cited by papers focused on Urinary Bladder and Prostate Research (5 papers), Sexual function and dysfunction studies (4 papers) and MicroRNA in disease regulation (4 papers). He Xiao collaborates with scholars based in China, United States and Poland. He Xiao's co-authors include Ge Wang, Fei Yin, Jianhui Liu, Lixia Guo, Bijing Mao, Dong Wang, Xinghuan Wang, Xuxu Zheng, Michael E. DiSanto and Xinhua Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Carcinogenesis.

In The Last Decade

He Xiao

39 papers receiving 567 citations

Peers

Countries citing papers authored by He Xiao

Since Specialization

Citations

This map shows the geographic impact of He Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Xiao more than expected).

Fields of papers citing papers by He Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by He Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Xiao. The network helps show where He Xiao may publish in the future.

Co-authorship network of co-authors of He Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of He Xiao. A scholar is included among the top collaborators of He Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with He Xiao. He Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognosis value of circulating tumor cell PD‑L1 and baseline characteristics in patients with NSCLC treated with immune checkpoint inhibitors plus platinum‑containing drugs 2024 ·Oncology Letters ·(unknown), (unknown), Shu Chen, Qiang Ma, He Xiao, Qian Chen, Hua Zou	1
2	Impact of APOBEC3s on the occurrence, development and prognosis of esophageal squamous cell carcinoma 2024 ·Future Oncology ·(unknown), He Xiao, Xiaoyan Dai, Mingfang Xu, Mengxia Li, (unknown), (unknown)	1
3	Prognostic effect of DNA methylation of BTG2 gene in Chinese hepatocellular carcinoma 2024 ·Heliyon ·(unknown), Zhuo Chen, (unknown), Chuan Chen, Wei Guan, (unknown), He Xiao, Bijing Mao, Bin Wang	3
4	Negative prognostic impact of Co-mutations in TGFβ and TP53 pathways in surgically resected rectal tumors following neoadjuvant chemoradiotherapy 2024 ·European Journal of Surgical Oncology ·Chengyuan Qian, Weina Yang, Mengxia Li, Yan Feng, Nan Dai, Hao Luo, (unknown), Xuemei Li, Yuxin Yang, Yue He, Dong Wang, Chunxue Li, He Xiao	1
5	Distinct circulating cytokine/chemokine profiles correlate with clinical benefit of immune checkpoint inhibitor monotherapy and combination therapy in advanced non‐small cell lung cancer 2023 ·Cancer Medicine ·(unknown), (unknown), He Xiao, Yanli Xiong, (unknown), Xiao Yang, Wei Luo, Jiamin Luo, Shiheng Zhang, Yi Cheng, Lei Zhang, Xiaoyan Dai, Yuxin Yang, Dong Wang, Mengxia Li	13
6	A subset of VEGFR‐TKIs activates AMPK in LKB1‐mutant lung cancer 2022 ·Cancer Science ·(unknown), Qin Zhang, Yanli Xiong, (unknown), He Xiao, Qian Chen, Xiaoyan Dai, Lei Zhang, (unknown), Dong Wang, Mengxia Li	5
7	Elevated tumor markers for monitoring tumor response to immunotherapy 2022 ·EClinicalMedicine ·Yi Yang, Xiaolin Jiang, Yun Liu, Huan Huang, Yanli Xiong, He Xiao, (unknown), Xuemei Li, (unknown), Xueqin Yang	4
8	Serum Aβ Levels are Associated with Age-related Cataract 2021 ·Neurotoxicity Research ·(unknown), Geng Zhao, Bo Yang, He Xiao, Zhiqiang Wang, Jian Ye	3
9	MTSS1 inhibits metastatic potential and induces G2/M phase cell cycle arrest in gastric cancer 2019 ·SHILAP Revista de lepidopterología ·Kun Liu, (unknown), (unknown), (unknown), Yongzhong Wu, Wen Chen, Jia Liu, He Xiao, (unknown)	1
10	Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia 2019 ·Frontiers in Endocrinology ·(unknown), (unknown), He Xiao, Xinghuan Wang, Michael E. DiSanto, Xinhua Zhang	18
11	Testosterone regulates myosin II isoforms expression and functional activity in the rat prostate 2018 ·The Prostate ·Ping Chen, He Xiao, Wei Huang, (unknown), Yuming Guo, Xiao Wang, Xinghuan Wang, Michael E. DiSanto, Xinhua Zhang	7
12	Blebbistatin modulates prostatic cell growth and contrapctility through myosin II signaling 2018 ·Clinical Science ·Ping Chen, (unknown), Shengli Xu, He Xiao, (unknown), Xinghuan Wang, Michael E. DiSanto, Xinhua Zhang	6
13	Upregulation of Oxytocin Receptor in the Hyperplastic Prostate 2018 ·Frontiers in Endocrinology ·Zhuo Li, He Xiao, Kebing Wang, (unknown), Ping Chen, Xinghuan Wang, Michael E. DiSanto, Xinhua Zhang	20
14	The expression and functional activities of smooth muscle myosin and non‐muscle myosin isoforms in rat prostate 2017 ·Journal of Cellular and Molecular Medicine ·Ping Chen, Jing Yin, Yuming Guo, He Xiao, Xinghuan Wang, Michael E. DiSanto, Xinhua Zhang	11
15	Testosterone regulates the expression and functional activity of sphingosine‐1‐phosphate receptors in the rat corpus cavernosum 2017 ·Journal of Cellular and Molecular Medicine ·Jing Yin, Yuming Guo, Ping Chen, He Xiao, Xinghuan Wang, Michael E. DiSanto, Xinhua Zhang	11
16	Association of polymorphisms of A260G and A386G in DAZL gene with male infertility: a meta-analysis and systemic review 2015 ·Asian Journal of Andrology ·Xinhua Zhang, Ping Chen, Xinghuan Wang, Chang Xu, He Xiao, (unknown)	12
17	MicroRNA-21 regulates the expression of BTG2 in HepG2 liver cancer cells 2015 ·Molecular Medicine Reports ·Bijing Mao, He Xiao, Zhimin Zhang, Dong Wang, Ge Wang	32
18	Genetic association of obsessive-compulsive disorder and serotonin transporter gene polymorphisms:A meta-analysis of data from case-control studies 2012 ·Zhongguo xinli weisheng zazhi ·He Xiao	1
19	Expression of PEG10 and SIAH2 in hepatocellular carcinoma and their clinical implications 2012 ·Experimental Pathology ·He Xiao	1
20	Glucagon-like peptide 1 receptor plays an essential role in geniposide attenuating lipotoxicity-induced β-cell apoptosis 2012 ·Toxicology in Vitro ·Jianhui Liu, Fei Yin, He Xiao, Lixia Guo, Xue Gao	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact